You are here: Industry Insights > china

News List

DHL strengthens in China biospectrumasia
April 14, 2017
DHL Global Forwarding has certified its air freight station in Shanghai per the CEIV Pharma Standard of the International Air Transport Association
ShangPharma Innovation appoints new CEO biospectrumasia
April 14, 2017
ShangPharma Innovation is a newly incorporated division of the ShangPharma Group
Space of Me-too Pharmaceutical Products to Choose the Easy Way Out to be Compressed in China en-cphi.cn
April 07, 2017
For a long time, it generally takes 3-5 years or even longer for new drugs of transnational companies from being approved to be marketed overseas to being marketed in China.
AAHRPP accredits nine more research organizations pharmaasia
April 05, 2017
The Association for the Accreditation of Human Research Protection Programs announced that it has accredited nine more research organizations.
USANA Subsidiary, BabyCare, Holds Grand Opening Of $40 Million State-Of-The-Art Facility In China en-cphi
March 28, 2017
Worldwide health and nutrition company, USANA Health Sciences, announces that its China subsidiary, BabyCare Ltd., held a grand opening for its new $40 million state-of-the-art manufacturing facility on March 21, 2017.
AstraZeneca's medicine approved under China’s Priority Review pharmafile
March 28, 2017
AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under China’s new Priority Review pathway.
ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner en-cphi.cn
March 27, 2017
ShangPharma announced today the intent for a strategic corporate restructuring.
Sanofi CEO Olivier Brandicourt's 2017 China Visit en-cphi
March 23, 2017
From March 18-22, Sanofi CEO Olivier Brandicourt paid his first visit to China in 2017. During the five-day trip he participated in the 2017 China Development Forum (CDF) in Beijing...
J&J chief Gorsky, in China for official summit, straddles Trump's globalism divide fiercepharma
March 23, 2017
Amid uncertainty for pharma as President Donald Trump embarks on his quest of putting “America First,” Johnson & Johnson CEO Alex Gorsky played down the potential fallout for his company during a CNBC interview Monday.
China proposes new FDA rules to speed up foreign drug approvals fiercepharma
March 23, 2017
China's FDA published (Chinese) a slate of suggested amendments to its foreign drug registration rules Friday, which could dramatically revamp the country’s pharmaceutical market landscape by eliminating hurdles that slow approvals of Western drugs.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page